Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Estrogen Receptor-positive Breast Cancer × Letrozole × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Ovarian Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Estrogen Receptor-positive Breast Cancer 1 Brain Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Letrozole 1 Diet, Ketogenic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03962647 2024-10-15

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Completed

Estrogen Receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡